Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Our path starts here
Join us on our journey as we drive scientific research to improve patient treatments for tomorrow.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Adjunct Professor, Bioinformatics and Structural Biology Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Adjunct Professor, Bioinformatics and Structural Biology Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Drug Discovery and Technology
SBP has the talent and resources to accelerate the development of new therapeutics.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Shared Resources
Our cores provide advanced technology, expertise and instrumentation to investigators.
Other Platforms
SBP innovates and maintains key technologies and partnerships to facilitate research.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Shared Resources
Our cores provide advanced technology, expertise and instrumentation to investigators.
Other Platforms
SBP innovates and maintains key technologies and partnerships to facilitate research.
In the News
February 13, 2019
STATE OF THE HEART: Coronary advances revealed at La Jolla's Sanford Burnham Prebys
Beaker Blog February 8, 2019
Nobel laureate Michael Rosbash presents his latest fruit-fly research at SBP
Read more
Beaker Blog February 7, 2019
Drug screen conducted at SBP identifies new therapeutic avenues for Alzheimer’s disease
Read more
Press Release
February 4, 2019
New insights into how HIV evades the immune system aid quest for better treatments
Beaker Blog January 29, 2019
Padres Pedal the Cause presents record-breaking check for nearly $3 million to fund local cancer research
Read more
Beaker Blog January 29, 2019
SBP scientist presents at Fleet Science Center to help the public better understand precision medicine
Read more
In the News
January 25, 2019
Understanding a Rare Cancer in Duchenne Muscular Dystrophy Patients
Events
5.7m
5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. SBP research hopes to change that.
Support us
Your support is vital to accelerating scientific discoveries to improve human health.